Purnartha Pratham

Scheme Rating

IME Scheme Rating

3 of 5 stars

Only for investors with high risk appetite: While it is still early days of the strategy, we are confident that the team will replicate their performance in their PMS fund as well. We recommend this strategy only for investor with a high risk appetite given the high concentration the strategy follows.

IME Strategy Rating

3 of 5 stars

Concentrated Multi-cap strategy: Purnartha Long Term Equity is a highly concentrated multi-cap portfolio (6-8 holdings) that aims to identify long term investments with high growth potential and strong balance sheets. Purnartha has a very strong investment strategy. We especially like the concentration that the strategy follows.

PMS Scheme Ratings are driven by IME’s Proprietary Scheme Rating Methodology, which takes into account our ratings of the Scheme’s investment strategy, its maturity, the investment team, and our separate rating on the AMC that runs this particular scheme. Our views on each of these individual criteria are available via the IME RMS – which you can view by reaching out to one of our relationship managers (using either the live chat or book appointment feature on this site).

IME View on Purnartha Pratham

Type: | | AUM (1391.1 cr) | Inc Date (28 Jul 2021)

Trailing Performance

1yr 3yr 5yr Since Inception
Purnartha Pratham 35.8 11.3 13.2
S&P BSE 500 TRI 39.5 19.5 25.1
Alpha over Broad Mkt BM -3.7 -8.2 -11.9
Nifty 500 38.4 18.1
Alpha over Category BM -2.6 -6.8

Performance as of: 28-Feb-23 | Inception Date: 28-Jul-21

Fund Managers

Rohit Jain | 3-star rated FM

Fund Manager | 16 yrs Experience | 3 yrs at current firm

Past Experience: Lead analyst(Crisil Global)

Fund Manager Profile: Rohit is a Chartered Accountant and holds a Post-graduate diploma in Business Management. He has worked with CRISIL (an S&P Global Company) and Systematix Shares among others and carries over 13 years of experience in Equity Research for Institutional investors. Over the years, he has built extensive knowledge in financial modeling and valuations with sector expertise across major industries. Rohit also keeps himself updated on the latest developments on taxation, auditing, and compliance, which only adds to his existing wealth management and market know-how.

Fee Structure

Fee StructureFee
Fixed Fee Structure
Variable Fee Structures2.5% fixed + 20% above 25% hurdle
Exit Fees


AMC: Purnartha PMS (click link for detailed AMC review)

Not a top recommendation as it is still a young AMC at this time : Started in 2011 as a RIA, Purnartha has established their research credentials and stock selection. While it is still early days in the PMS and AIF offerings (launched in 2020), we are positive on the AMC & teams pedigree, and the ability of their research to identify quality ideas. A higher than normal level of concentration makes this more suitable for higher-risk investors.

AMC Rating

3 of 5 stars

AMC Pedigree

4 of 5 stars

AMC Size

4 of 5 stars

Team Pedigree

4 of 5 stars

Inv Philosophy

4 of 5 stars


3 of 5 stars

Get substantially greater insights by connecting with us!

Details shared on the public website, are only a short snapshot of the more detailed analysis that resides in our Proprietary Research Management Solution (RMS) – A proprietary cloud-based tool, that ensures that the unbiased research insights of our central research team are shared directly with investors.

Our RMS allows us to operate with a level of transparency, ethics & consistency of insights, that is unparrarelled in the industry. Our RM’s will help showcase the PMS/AIF options that are the most suited for your unique requirements.

Download Sample RMS Reports: AMC View | Scheme Comparison

Note: PMS AMC & Scheme Reviews and Ratings are based on IME Capital’s Proprietary Review and Rating Methodology (read more here: AMC Rating & Scheme Ratings). These reflect the unbiased views of our central research team, based on our assessment of the investment value of these PMS/AIF strategies for our investors. We follow a highly stringent rating-criteria, where approximately 50% of PMS AMC’s & strategies would be rated 2-star or below (this is not meant to indicate that these funds are not investment-worthy, but that they do not currently fulfill the requirements we focus on for recommending funds to our investors — based on our internal views on the merit of the AMC/strategy relative to peers). Reviews & Ratings are primarily based on research of publicly available information (SEBI disclosures, PMS websites, PMS-aggregation platforms, webinar recording, media interviews etc.) and no explicit consent is required from AMCs for the same. While we endeavour to do further due-diligence via direct interactions with the investment teams of AMCs, this is typically restricted to AMC’s that meet our foundational fund selection criteria (reviews on lower-rated AMCs are often based solely on publicly available information). The views reflected in our Reviews & Ratings, are our independent views and may not be shared by the AMC’s and the investment teams. Please read detailed disclaimer for more.